GENDREAU R MICHAEL 4
4 · CYPRESS BIOSCIENCE INC · Filed Jan 6, 2010
Insider Transaction Report
Form 4
GENDREAU R MICHAEL
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2010-01-04+40,000→ 40,000 totalExercise: $6.03Exp: 2020-01-04→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest daily and ratably over four years from the date of grant, such that the option shall be fully vested on January 4, 2014.